Premium
Omni Bridgeway Ltd (PK) (IMMFF)
USOTC
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
VANCOUVER, British Columbia, Aug. 10, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd., (Pink Sheets:IMMFF), reports that its business partner Immunitor company has launched a Phase 2 clinical trial...
VANCOUVER, British Columbia, July 9, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that Immunitor's investigators presented final results from its imm01 clinical trial...
VANCOUVER, British Columbia, July 7, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that clinical results from its new tableted form of Immunoxel (Dzherelo) product...
Agreement to fast-track introduction of new Immunoxel/Dzherelo tablet as adjunct immunotherapy, especially for MDR-TB VANCOUVER, British Columbia, May 30, 2011 (GLOBE NEWSWIRE) -- Immune...
VANCOUVER, British Columbia, March 3, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that Ukrainian company Ekomed LLC has agreed to collaborate with Immune Network and...
VANCOUVER, B.C., Feb. 28, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that Immunitor will present latest results from its imm01 clinical trial in tuberculosis...
VANCOUVER, British Columbia, Feb. 14, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) is pleased to announce that a co-founder of Immunitor, Dr. Aldar Bourinbaiar, has joined...
VANCOUVER, British Columbia, Jan. 24, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd., (Pink Sheets:IMMFF) a company in the business of development and commercialization of immune therapies...
VANCOUVER, British Columbia, Jan. 17, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises progress is being made toward the acquisition of Immunitor Inc., a Canadian...
VANCOUVER, British Columbia, Dec. 30, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that Immunitor has published data from the first half of the 120-patient imm01...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.5 | 0.5 | 0.5 | 0 | 0 | CS |
| 26 | -0.11 | -18.0327868852 | 0.61 | 0.61 | 0.5 | 20 | 0.5 | CS |
| 52 | -0.3993 | -44.4012009341 | 0.8993 | 0.9897 | 0.5 | 2434 | 0.67291888 | CS |
| 156 | -1.7 | -77.2727272727 | 2.2 | 3.22925 | 0.5 | 3283 | 1.75673574 | CS |
| 260 | -1.35 | -72.972972973 | 1.85 | 6.9 | 0.5 | 6837 | 2.63356546 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| CBDLCBD Life Sciences Inc (PK) | US$ 0,0004 (33,33%) | 237,45M |
| RDARRaadr Inc (PK) | US$ 0,0006 (-14,29%) | 212,99M |
| CGACCode Green Apparel Corp (PK) | US$ 0,00045 (-35,71%) | 196,42M |
| AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0,0034 (29,52%) | 174,82M |
| NSAVNet Savings Link Inc (PK) | US$ 0,0008 (-55,56%) | 170,05M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
